Drug profile · INN
hydroflumethiazide
HYDROFLUMETHIAZIDE AND RESERPINE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
hydroflumethiazide (HYDROFLUMETHIAZIDE AND RESERPINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN hydroflumethiazide
Brand HYDROFLUMETHIAZIDE AND RESERPINE
Route ORAL
Formulation TABLET
Frequently asked questions
What is hydroflumethiazide?
hydroflumethiazide (HYDROFLUMETHIAZIDE AND RESERPINE) is an FDA-listed pharmaceutical active ingredient. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for hydroflumethiazide?
HYDROFLUMETHIAZIDE AND RESERPINE is a marketed brand name for hydroflumethiazide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of hydroflumethiazide?
hydroflumethiazide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.